Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs

C Chen, L Xie, T Ren, Y Huang, J Xu, W Guo - Cancer letters, 2021 - Elsevier
Osteosarcoma (OS) is the most common primary malignancy of the bone and has a high
propensity for local invasion and metastasis. Although combining surgery with …

Advances on immunotherapy for osteosarcoma

S Yu, X Yao - Molecular Cancer, 2024 - Springer
Osteosarcoma is the most common primary bone cancer in children and young adults.
Limited progress has been made in improving the survival outcomes in patients with …

The osteosarcoma microenvironment: a complex but targetable ecosystem

I Corre, F Verrecchia, V Crenn, F Redini, V Trichet - Cells, 2020 - mdpi.com
Osteosarcomas are the most frequent primary bone sarcomas, affecting mainly children,
adolescents, and young adults, and with a second peak of incidence in elderly individuals …

Ewing sarcoma—diagnosis, treatment, clinical challenges and future perspectives

SK Zöllner, JF Amatruda, S Bauer, S Collaud… - Journal of clinical …, 2021 - mdpi.com
Ewing sarcoma, a highly aggressive bone and soft-tissue cancer, is considered a prime
example of the paradigms of a translocation-positive sarcoma: a genetically rather simple …

Engineered T cells: the promise and challenges of cancer immunotherapy

AD Fesnak, CH June, BL Levine - Nature reviews cancer, 2016 - nature.com
The immune system evolved to distinguish non-self from self to protect the organism. As
cancer is derived from our own cells, immune responses to dysregulated cell growth present …

Tumor buster-where will the CAR-T cell therapy 'missile'go?

C Qu, H Zhang, H Cao, L Tang, H Mo, F Liu, L Zhang… - Molecular Cancer, 2022 - Springer
Chimeric antigen receptor (CAR) T cell (CAR-T cell) therapy based on gene editing
technology represents a significant breakthrough in personalized immunotherapy for human …

The WNT/ROR pathway in cancer: from signaling to therapeutic intervention

K Menck, S Heinrichs, C Baden, A Bleckmann - Cells, 2021 - mdpi.com
The WNT pathway is one of the major signaling cascades frequently deregulated in human
cancer. While research had initially focused on signal transduction centered on β-catenin as …

CAR T‐cell therapy of solid tumors

CSM Yong, V Dardalhon, C Devaud… - Immunology and cell …, 2017 - Wiley Online Library
The potential for immunotherapy as a treatment option for cancer is clear from remarkable
responses of some leukemia patients to adoptive cell transfer using autologous T cells …

Immunotherapy for osteosarcoma: where do we go from here?

MF Wedekind, LM Wagner, TP Cripe - Pediatric blood & cancer, 2018 - Wiley Online Library
Osteosarcoma is the most common bone tumor in children and young adults, with few
advances in survival and treatment, especially for metastatic disease, in the last 30 years …

[HTML][HTML] Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness

M Panagi, P Pilavaki, A Constantinidou… - Theranostics, 2022 - ncbi.nlm.nih.gov
Sarcomas are uncommon malignancies of mesenchymal origin that can arise throughout the
human lifespan, at any part of the body. Surgery remains the optimal treatment modality …